You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

17-251

Showing 1 - 25 of 4,681
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Migraine With or Without Aura Trial in Worldwide (Placebo, Eletriptan 40 mg, Eletriptan 80 mg)

Completed
  • Migraine With or Without Aura
  • Placebo
  • +2 more
  • Arhus C, Denmark
  • +42 more
Jan 26, 2021

Schizophrenia Trial in Worldwide (BI 425809, Placebo)

Recruiting
  • Schizophrenia
  • Little Rock, Arkansas
  • +80 more
Jan 23, 2023

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Trial in Worldwide (Tolvaptan)

Completed
Has Results
  • Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  • Mobile, Alabama
  • +96 more
Sep 27, 2021

Atrial Fibrillation Trial in Worldwide

Recruiting
  • Atrial Fibrillation
    • Urbana, Illinois
    • +157 more
    Jan 18, 2023

    Uterine Fibroids Trial in Worldwide (Vilaprisan (BAY1002670), Placebo)

    Terminated
    Has Results
    • Uterine Fibroids
    • Vilaprisan (BAY1002670)
    • Placebo
    • Canyon Country, California
    • +86 more
    Jun 29, 2022

    Acute Myocardial Infarction, Heart Failure Trial in Sweden, United Kingdom (Dapagliflozin, Placebo)

    Recruiting
    • Acute Myocardial Infarction
    • Heart Failure
    • Alingsås, Sweden
    • +112 more
    Aug 18, 2022

    Pain, Interleukin, Vessels; Varicose Trial in Kahramanmaras (Group A ( Group Acupuncture))

    Completed
    • Pain
    • +2 more
    • Group A ( Group Acupuncture)
    • Kahramanmaraş, Onikişubat, Turkey
      Kahramanmaras Sutcu Imam University Faculty of Medicine
    Mar 12, 2019

    Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV Trial in Worldwide (Selumetinib, Docetaxel, Placebo)

    Active, not recruiting
    Has Results
    • Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
    • Aurora, Colorado
    • +196 more
    Dec 22, 2022

    Neuroblastoma (NB) Trial in New York (Irinotecan, temozolomide, Hu3F8)

    Active, not recruiting
    • Neuroblastoma (NB)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Oct 19, 2021

    Periodontitis Trial (No intervention was applied to the groups the samples will be collected in terms of the diagnosis

    Not yet recruiting
    • Periodontitis
    • No intervention was applied to the groups the samples will be collected in terms of the diagnosis (periodontitis, healthy)
    • (no location specified)
    Mar 31, 2022

    Iron Deficiency Anemia Trial in Waltham (Ferumoxytol)

    Terminated
    Has Results
    • Iron Deficiency Anemia
    • Waltham, Massachusetts
      AMAG Pharmaceuticals, Inc.
    Mar 31, 2022

    Allergy Trial in Worldwide (SQ tree SLIT-tablet, Placebo)

    Recruiting
    • Allergy
    • SQ tree SLIT-tablet
    • Placebo
    • Vienna, Austria
    • +83 more
    Dec 21, 2022

    Knee Osteoarthritis Trial in Hungary, Poland (combination product, device, drug)

    Completed
    Has Results
    • Knee Osteoarthritis
    • Cingal
    • +2 more
    • Budapest,, Hungary
    • +18 more
    Feb 23, 2022

    Allergic Rhinitis Due to Grass Pollen Trial in Lublin (Ismigen, Placebo)

    Completed
    • Allergic Rhinitis Due to Grass Pollen
    • Lublin, Poland
      Department of Pulmonary Diseases and Children Rheumatology, Medi
    Apr 2, 2022

    Pregnancy Prevention Trial in Raleigh (Levonorgestrel 1.5mg, Meloxicam 15 mg, Placebo)

    Recruiting
    • Pregnancy Prevention
    • Levonorgestrel 1.5mg
    • +2 more
    • Raleigh, North Carolina
      Carolina Women's Research and Wellness Center
    Jan 12, 2023

    Alendronate inWeekly Effervescent Tablet Formulation Following

    Recruiting
    • Postmenopausal Osteoporosis
    • Binosto 70Mg Effervescent Tablet
    • Athens, Attiki, Greece
      251 Hellenic Air Force & VA General Hospital
    Nov 6, 2022

    MDD Trial (GATE-251, Placebo)

    Completed
    • Major Depressive Disorder
    • (no location specified)
    Jul 28, 2021

    Postoperative Complications, COVID-19 Trial in Bucharest

    Recruiting
    • Postoperative Complications
    • COVID-19
      • Bucharest, Romania
      • +1 more
      Feb 28, 2023

      FSHD Molecular Characterization

      Recruiting
      • Facio-Scapulo-Humeral Dystrophy
        • Columbus, Ohio
          The Abigail Wexner Research Institute at Nationwide Children's H
        Oct 20, 2023

        Multiple Sclerosis Trial in Muenster (311 nm narrowband UVB irradiation)

        Recruiting
        • Multiple Sclerosis
        • 311 nm narrowband UVB irradiation
        • Muenster, NRW, Germany
          University Hospital Muenster
        Nov 16, 2022

        Migraine Headache Trial in United States (DFN-15 Active, DFN-15 Placebo)

        Completed
        Has Results
        • Migraine Headache
        • DFN-15 Active
        • DFN-15 Placebo
        • Birmingham, Alabama
        • +42 more
        Dec 15, 2022

        COPD Trial in Rahim yar khan (Anterior Chest Compression technique, Abdominal Thrust Technique)

        Not yet recruiting
        • COPD
        • Anterior Chest Compression technique
        • Abdominal Thrust Technique
        • Rahim yar khan, Punjab, Pakistan
          Sheikh Zayed Hospital, Rahim Yar Khan.
        Jul 7, 2023

        Dental Pulp Disease, Periapical Diseases, Tooth, Nonvital Trial in Adana (MTAD irrigation)

        Completed
        • Dental Pulp Disease
        • +2 more
        • MTAD irrigation
        • Adana, Turkey
          Cukurova University
        Sep 22, 2022

        RLS Trial in United States (HORIZANT 600 mg)

        Recruiting
        • RLS
        • HORIZANT 600 mg
        • Redwood City, California
        • +10 more
        Jun 7, 2021

        Augmented Reality Usage in Gynecological Laparoscopy on Patients

        Active, not recruiting
        • Myoma;Uterus
        • Adenomyoma of Uterus
        • Gynecological laparoscopic surgery without augmented reality
        • Gynecological laparoscopic surgery with augmented reality
        • Clermont-Ferrand, France
          CHU clermont-ferrand
        Jun 29, 2023